HILLARY WILCOX: Open Payments
NPI 1962116749 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 20 payments from 10 companies in 2025. Trend: 2023 $39 · 2024 $358 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $143 |
| Sage Therapeutics, LLC | 3 | $81 |
| Organon LLC | 2 | $58 |
| Hologic Sales and Service, LLC | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Evofem Biosciences, Inc. | 1 | $23 |
| CooperSurgical, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: Veozah, ZURZUVAE, NEXPLANON, APTIMA, Mirena, GEMTESA, Phexxi, Paragard T 380A.
Industry payments across MD — which companies pay providers there.
